These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6120529)

  • 21. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.
    Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S
    Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schizophrenia and platelet monoamine oxidase: research strategies.
    Buchsbaum MS; Coursey RD; Murphy DL
    Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    J Affect Disord; 1984 Dec; 7(3-4):265-72. PubMed ID: 6151957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z; Arató M; Bagdy G
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia.
    Baron M; Levitt M; Perlman R
    Psychiatry Res; 1980 Dec; 3(3):329-35. PubMed ID: 6936727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A primer on geriatric psychopharmacology.
    Salzman C
    Am J Psychiatry; 1982 Jan; 139(1):67-74. PubMed ID: 6119909
    [No Abstract]   [Full Text] [Related]  

  • 31. Research as an impetus to improved treatment.
    Carroll RS; Miller A; Ross B; Simpson GM
    Arch Gen Psychiatry; 1980 Apr; 37(4):377-80. PubMed ID: 6102460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic drug therapy in children and adolescents.
    Wiener JM
    Psychosomatics; 1982 May; 23(5):488-91, 494-5. PubMed ID: 6125987
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet-monoamine-oxidase activity predicts response to lithium in manic-depressive illness.
    Sullivan JL; Cavenar JO; Maltbie A; Stanfield C
    Lancet; 1977 Dec 24-31; 2(8052-8053):1325-7. PubMed ID: 74733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients.
    Sofuoğlu S; Doğan P; Köse K; Eşel E; Baştũrk M; Oğuz H; Gönül AS
    Psychiatry Res; 1995 Nov; 59(1-2):165-70. PubMed ID: 8771233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment of manic and depressive illness.
    Ostow M
    Compr Ther; 1985 Jul; 11(7):24-30. PubMed ID: 2863029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet monoamine oxidase activity in affective disorders.
    Reveley MA; Glover V; Sandler M; Coppen A
    Psychopharmacology (Berl); 1981; 73(3):257-60. PubMed ID: 6787645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third Psychoactive Drug Usage Guide.
    Appleton WS
    Dis Nerv Syst; 1976 Jan; 37(1):39-51. PubMed ID: 1212
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet monoamine oxidase in affective illness and alcoholism.
    Belmaker RH; Bracha HS; Ebstein RP
    Schizophr Bull; 1980; 6(2):320-3. PubMed ID: 7375864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of borderline disorders.
    Soloff PH
    Compr Psychiatry; 1981; 22(6):535-43. PubMed ID: 6118234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.